Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US20040127534A1
公开(公告)日:2004-07-01
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
6,7-二氢-5H-咪唑[1,2-a]咪唑-3-磺酰胺基-丙酰胺的衍生物在抑制细胞黏附分子(CAMs)和白细胞整合素相互作用方面表现良好,因此在治疗炎症性疾病方面具有用处。